查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1869882

足底筋膜炎治疗市场规模、份额和趋势分析报告：按药物类别、疾病类型、最终用途、地区和细分市场预测（2025-2033 年）

Plantar Fasciitis Treatment Market Size, Share & Trends Analysis Report By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids), By Disease Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

足底筋膜炎治疗市场摘要

2024年全球足底筋膜炎治疗市场规模估计为12.8亿美元，预计2033年将达到34.5亿美元。

预计从 2025 年到 2033 年，该市场将以 11.9% 的复合年增长率成长。推动这一市场成长的主要因素包括肥胖症的增加、人口老化，以及由于长时间站立工作和高强度活动而导致的脚跟和脚部压力增加。

意识提升、专业护理服务的可及性提高以及先进治疗方法的引入，正进一步推动市场扩张。医院、诊所和门诊机构越来越重视足部疾病的早期诊断和有效治疗。这些因素共同推动了对治疗性介入的需求，从而促进了足跟和足部护理领域的持续成长和创新。

儘管各国政府很少公布准确的全球病例数，但据估计，每年约有100万人次因足底筋膜炎就诊。研究表明，约10%的人口在其一生中的某个阶段会患上足底筋膜炎，其中83%为25至65岁的劳动年龄人口。据报道，跑步者的盛行率高达22%。

影像引导治疗、超音波导引註射以及微创机械和声学疗法的进步，使得治疗定位更加精准，恢復时间更短，疗效更佳，从而提高了医生和患者的接受度。 2025年7月发表于《美国物理医学与復健学会杂誌》的一项研究比较了富血小板血浆（PRP）和皮质类固醇治疗足底筋膜炎的疗效。结果表明，与皮质类固醇注射相比，PRP能更有效地缓解疼痛并改善足部功能。同样在2025年7月，勒克瑙国王乔治医科大学的研究人员研究了超音波导引葡萄糖增强疗法和PRP注射治疗慢性足跟痛的疗效。研究发现，两种治疗方法均能显着减轻疼痛并改善足部功能，其中PRP的效果略胜一筹。

目录

第一章调查方法和范围

第二章执行摘要

第三章 足底筋膜炎治疗市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析

第四章 足底筋膜炎治疗市场：药物类别商业分析

  • 按药物类别分類的市场份额，2024 年和 2033 年
  • 药物类别细分仪表板
  • 按药物类别分類的市场规模、预测和趋势分析，2021-2033年
  • 非类固醇消炎剂（NSAIDs）
  • 皮质类固醇
  • 其他的

第五章 足底筋膜炎治疗市场：疾病类型商业分析

  • 按疾病类型分類的市场份额，2024 年和 2033 年
  • 疾病类型细分仪表板
  • 按疾病类型分類的市场规模、预测和趋势分析，2021-2033年
  • 急性足底筋膜炎
  • 慢性足底筋膜炎
  • 其他的

第六章 足底筋膜炎治疗市场：终端用户业务分析

  • 按最终用途分類的市场份额，2024 年和 2033 年
  • 最终用户细分仪表板
  • 按最终用途分類的市场规模、预测和趋势分析（2021-2033 年）
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第七章 足底筋膜炎治疗市场：区域估算与趋势分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 按国家/地区划分，2021-2033 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区划分，2021-2033 年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 按国家/地区划分，2021-2033 年
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 按国家/地区划分，2021-2033 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区划分，2021-2033 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 参与者概览
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介
    • Pfizer Inc.
    • Bayer AG
    • Johnson &Johnson
    • Viatris Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • AbbVie Inc.
    • GSK plc.
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd.
Product Code: GVR-4-68040-780-9

Plantar Fasciitis Treatment Market Summary

The global plantar fasciitis treatment market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 3.45 billion by 2033, growing at a CAGR of 11.9% from 2025 to 2033. The market growth is driven by rising prevalence of obesity, an aging population, and an increase in heel and foot strain cases caused by prolonged standing or high-impact activities.

Increasing awareness among patients about foot health, better access to specialized care, and the adoption of advanced treatment options are further supporting market expansion. Hospitals, clinics, and outpatient facilities are emphasizing early diagnosis and effective management of foot-related conditions. Combined, these factors are fueling demand for therapeutic interventions, driving consistent growth and encouraging innovation within the heel and foot care segment.

Although governments rarely provide exact global case figures, estimates suggest that approximately 1 million patient visits yearly are due to plantar fasciitis. Research indicates that around 10% of the population experience plantar fasciitis at some point, with 83% of affected individuals being active working adults aged 25 to 65. Some studies report prevalence rates as high as 22% among runners.

Developments in image-guided interventions, ultrasound-guided injections, and minimally invasive mechanical or sonic therapies improve targeting, reduce recovery time, and enhance efficacy, thus increasing physician and patient adoption. In July 2025, a study published in the American Journal of Physical Medicine & Rehabilitation compared the efficacy of platelet-rich plasma (PRP) and corticosteroids in treating plantar fasciitis. The results indicated that PRP provided superior pain relief and improved foot function over corticosteroid injections. In addition, in July 2025, a study by King George's Medical University researchers in Lucknow explored the effectiveness of ultrasound-guided dextrose prolotherapy versus PRP injections for chronic heel pain. The study found that both treatments significantly reduced pain and improved foot function, with PRP demonstrating slightly superior outcomes.

Global Plantar Fasciitis Treatment Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global plantar fasciitis treatment market report based on drug class, disease type, end use, and region:

  • Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Others
  • Disease Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Acute Plantar Fasciitis
  • Chronic Plantar Fasciitis
  • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Disease Type
    • 1.2.3. End Use
    • 1.2.4. Region
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Plantar Fasciitis Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Plantar Fasciitis Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2033
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
  • 4.4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • 4.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 4.5. Corticosteroids
    • 4.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 4.6. Others
    • 4.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Plantar Fasciitis Treatment Market: Disease Type Business Analysis

  • 5.1. Disease Type Market Share, 2024 & 2033
  • 5.2. Disease Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2021 to 2033 (USD Billion)
  • 5.4. Acute Plantar Fasciitis
    • 5.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 5.5. Chronic Plantar Fasciitis
    • 5.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 5.6. Others
    • 5.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Plantar Fasciitis Treatment Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2033
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
  • 6.4. Hospitals & Clinics
    • 6.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.6. Others
    • 6.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Plantar Fasciitis Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 7.4. North America
    • 7.4.1. North America Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. Canada Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5. Europe
    • 7.5.1. Europe Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. UK Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7. Latin America
    • 7.7.1. Latin America Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Brazil Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. Argentina Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Pfizer Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Bayer AG
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Johnson & Johnson
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Viatris Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Teva Pharmaceutical Industries Ltd.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Sanofi
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. AbbVie Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. GSK plc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Novartis AG
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sun Pharmaceutical Industries Ltd.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global plantar fasciitis treatment market, by region, 2021 - 2033 (USD Billion)
  • Table 4 Global plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 5 Global plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 6 Global plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 7 North America plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 8 North America plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 9 North America plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 10 North America plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 11 US plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 12 US plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 13 US plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 14 Canada plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 15 Canada plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 16 Canada plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 17 Mexico plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 18 Mexico plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 19 Mexico plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 20 Europe plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 21 Europe plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 22 Europe plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 23 Europe plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 24 UK plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 25 UK plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 26 UK plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 27 Germany plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 28 Germany plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 29 Germany plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 30 France plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 31 France plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 32 France plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 33 Italy plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 34 Italy plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 35 Italy plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 36 Spain plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 37 Spain plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 38 Spain plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 39 Denmark plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 40 Denmark plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 41 Denmark plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 42 Sweden plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 43 Sweden plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 44 Sweden plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 45 Norway plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 46 Norway plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 47 Norway plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 48 Asia Pacific plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 49 Asia Pacific plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 50 Asia Pacific plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 51 Asia Pacific plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 52 Japan plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 53 Japan plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 54 Japan plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 55 China plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 56 China plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 57 China plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 58 India plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 59 India plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 60 India plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 61 Australia plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 62 Australia plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 63 Australia plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 64 South Korea plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 65 South Korea plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 66 South Korea plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 67 Thailand plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 68 Thailand plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 69 Thailand plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 70 Latin America plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 71 Latin America plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 72 Latin America plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 73 Latin America plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 74 Brazil plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 75 Brazil plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 76 Brazil plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 77 Argentina plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 78 Argentina plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 79 Argentina plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 80 Middle East & Africa plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 81 Middle East & Africa plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 82 Middle East & Africa plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 83 Middle East & Africa plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 84 South Africa plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 85 South Africa plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 86 South Africa plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 87 Saudi Arabia plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 88 Saudi Arabia plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 89 Saudi Arabia plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 90 UAE plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 91 UAE plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 92 UAE plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 93 Kuwait plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 94 Kuwait plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 95 Kuwait plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Plantar fasciitis treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Billion)
  • Fig. 10 Competitive landscape
  • Fig. 11 Plantar fasciitis treatment market dynamics
  • Fig. 12 Plantar fasciitis treatment market: Porter's five forces analysis
  • Fig. 13 Plantar fasciitis treatment market: PESTLE analysis
  • Fig. 14 Plantar fasciitis treatment market: Drug class movement analysis
  • Fig. 15 Plantar fasciitis treatment market: Drug class outlook and key takeaways
  • Fig. 16 Nonsteroidal anti-inflammatory drugs (NSAIDs) market estimates and forecast, 2021 - 2033
  • Fig. 17 Corticosteroids market estimates and forecast, 2021 - 2033
  • Fig. 18 Others market estimates and forecast, 2021 - 2033
  • Fig. 19 Plantar fasciitis treatment market: Disease type movement analysis
  • Fig. 20 Plantar fasciitis treatment market: Disease type outlook and key takeaways
  • Fig. 21 Acute plantar fasciitis market estimates and forecast, 2021 - 2033
  • Fig. 22 Chronic plantar fasciitis market estimates and forecast, 2021 - 2033
  • Fig. 23 Others market estimates and forecast, 2021 - 2033
  • Fig. 24 Plantar fasciitis treatment market: End use movement analysis
  • Fig. 25 Plantar fasciitis treatment market: End use outlook and key takeaways
  • Fig. 26 Hospitals & clinics market estimates and forecast, 2021 - 2033
  • Fig. 27 Ambulatory surgical centers market estimates and forecast, 2021 - 2033
  • Fig. 28 Others market estimates and forecast, 2021 - 2033
  • Fig. 29 Plantar fasciitis treatment market: Regional movement analysis
  • Fig. 30 Plantar fasciitis treatment market: Regional outlook and key takeaways
  • Fig. 31 North America market estimates and forecast, 2021 - 2033
  • Fig. 32 U.S. market estimates and forecast, 2021 - 2033
  • Fig. 33 Canada market estimates and forecast, 2021 - 2033
  • Fig. 34 Mexico market estimates and forecast, 2021 - 2033
  • Fig. 35 Europe market estimates and forecast, 2021 - 2033
  • Fig. 36 UK market estimates and forecast, 2021 - 2033
  • Fig. 37 Germany market estimates and forecast, 2021 - 2033
  • Fig. 38 France market estimates and forecast, 2021 - 2033
  • Fig. 39 Italy market estimates and forecast, 2021 - 2033
  • Fig. 40 Spain market estimates and forecast, 2021 - 2033
  • Fig. 41 Denmark market estimates and forecast, 2021 - 2033
  • Fig. 42 Sweden market estimates and forecast, 2021 - 2033
  • Fig. 43 Norway market estimates and forecast, 2021 - 2033
  • Fig. 44 Asia Pacific market estimates and forecast, 2021 - 2033
  • Fig. 45 Japan market estimates and forecast, 2021 - 2033
  • Fig. 46 China market estimates and forecast, 2021 - 2033
  • Fig. 47 India market estimates and forecast, 2021 - 2033
  • Fig. 48 Australia market estimates and forecast, 2021 - 2033
  • Fig. 49 South Korea market estimates and forecast, 2021 - 2033
  • Fig. 50 Thailand market estimates and forecast, 2021 - 2033
  • Fig. 51 Latin America market estimates and forecast, 2021 - 2033
  • Fig. 52 Brazil market estimates and forecast, 2021 - 2033
  • Fig. 53 Argentina market estimates and forecast, 2021 - 2033
  • Fig. 54 Middle East & Africa market estimates and forecast, 2021 - 2033
  • Fig. 55 South Africa market estimates and forecast, 2021 - 2033
  • Fig. 56 Saudi Arabia market estimates and forecast, 2021 - 2033
  • Fig. 57 UAE market estimates and forecast, 2021 - 2033
  • Fig. 58 Kuwait market estimates and forecast, 2021 - 2033
  • Fig. 59 Company categorization
  • Fig. 60 Company market position analysis
  • Fig. 61 Strategic framework